Metraipolis › archive › dc_309501965117

Comparative Efficacy and Safety of Tirzepatide Versus Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis — Europe PMC PMID:41975852

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41975852
DOI
10.3390/healthcare14070850
License (as archived)
solo-consultazione
Archived
2026-11-03T19:36:10.115Z
SHA-256 of the archived text
a0057fac494884fb08b9a9fd676d817d0dbbb69f88d56ffd261cea25b249a6ea
Stable URL of this page
https://metraipolis.com/documento/dc_309501965117

How to cite

Comparative Efficacy and Safety of Tirzepatide Versus Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis — Europe PMC PMID:41975852 — Europe PMC (en), https://europepmc.org/article/MED/41975852 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_309501965117 (Metraipolis archive dc_309501965117, sha256 a0057fac494884fb08b9a9fd676d817d0dbbb69f88d56ffd261cea25b249a6ea)
BibTeX
@misc{dc309501965117,
  title = {Comparative Efficacy and Safety of Tirzepatide Versus Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis — Europe PMC PMID:41975852},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41975852},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_309501965117; sha256 a0057fac494884fb08b9a9fd676d817d0dbbb69f88d56ffd261cea25b249a6ea},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41975852. Agents can read the archived copy with the MCP tool read_document.